228 related articles for article (PubMed ID: 20124139)
21. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
[TBL] [Abstract][Full Text] [Related]
22. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
23. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
26. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance.
Clarson CL; Mahmud FH; Baker JE; Clark HE; McKay WM; Schauteet VD; Hill DJ
Endocrine; 2009 Aug; 36(1):141-6. PubMed ID: 19387874
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
[TBL] [Abstract][Full Text] [Related]
28. The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial.
Evia-Viscarra ML; Rodea-Montero ER; Apolinar-Jiménez E; Muñoz-Noriega N; García-Morales LM; Leaños-Pérez C; Figueroa-Barrón M; Sánchez-Fierros D; Reyes-García JG
J Pediatr Endocrinol Metab; 2012; 25(1-2):41-9. PubMed ID: 22570949
[TBL] [Abstract][Full Text] [Related]
29. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
Bridger T; MacDonald S; Baltzer F; Rodd C
Arch Pediatr Adolesc Med; 2006 Mar; 160(3):241-6. PubMed ID: 16520442
[TBL] [Abstract][Full Text] [Related]
30. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
[TBL] [Abstract][Full Text] [Related]
31. Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial.
Fox CK; Clark JM; Rudser KD; Ryder JR; Gross AC; Nathan BM; Sunni M; Dengel DR; Billington CJ; Bensignor MO; Kelly AS
Obesity (Silver Spring); 2022 May; 30(5):1105-1115. PubMed ID: 35403350
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
[TBL] [Abstract][Full Text] [Related]
33. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
[TBL] [Abstract][Full Text] [Related]
34. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
[TBL] [Abstract][Full Text] [Related]
35. Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals.
Rodríguez Y; Giri M; Feyen E; Christophe AB
Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):391-7. PubMed ID: 15519498
[TBL] [Abstract][Full Text] [Related]
36. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
37. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
Rosenstock J; Hollander P; Gadde KM; Sun X; Strauss R; Leung A;
Diabetes Care; 2007 Jun; 30(6):1480-6. PubMed ID: 17363756
[TBL] [Abstract][Full Text] [Related]
39. Optimal macronutrient content of the diet for adolescents with prediabetes; RESIST a randomised control trial.
Garnett SP; Gow M; Ho M; Baur LA; Noakes M; Woodhead HJ; Broderick CR; Burrell S; Chisholm K; Halim J; De S; Steinbeck K; Srinivasan S; Ambler GR; Kohn MR; Cowell CT
J Clin Endocrinol Metab; 2013 May; 98(5):2116-25. PubMed ID: 23533232
[TBL] [Abstract][Full Text] [Related]
40. Zonisamide for weight loss in obese adults: a randomized controlled trial.
Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
